Molecular Imaging Reveals a Role for AKT in Resistance to Cisplatin for Ovarian Endometrioid Adenocarcinoma

PURPOSE: Ovarian cancer is the fifth leading cause of cancer deaths among American women. Platinum-based chemotherapy, such as cisplatin, represents the standard of care for ovarian cancer. However, toxicity and acquired resistance to cisplatin have proven challenging in the treatment of ovarian can...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wang, Hanxiao, Galbán, Stefanie, Wu, Rong, Bowman, Brittany, Witte, Amanda, Vetter, Katrin, Galbán, Craig J., Ross, Brian D., Cho, Kathleen R., Rehemtulla, Alnawaz
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537896/
https://ncbi.nlm.nih.gov/pubmed/23095324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-2380
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars